Arvinas (ARVN) Consolidated Net Income (2017 - 2026)

Arvinas (ARVN) recorded quarterly Consolidated Net Income of -$57.6 million in Q1 2026, up 14.54% quarter-over-quarter from -$67.4 million in Q4 2025, and down 169.48% on a YoY basis from $82.9 million in Q1 2025.

Arvinas (ARVN) Consolidated Net Income (2017 - 2026) Analysis & Trends

Arvinas' Consolidated Net Income history runs 10 years deep, the most recent figure standing at -$57.6 million for Q1 2026.

  • In Q1 2026, Consolidated Net Income fell 169.48% year-over-year to -$57.6 million; the TTM figure through Mar 2026 stood at -$221.3 million (down 374.89% YoY), while the FY2025 annual figure was -$80.8 million, up 59.38% from the prior year.
  • Consolidated Net Income was -$57.6 million for Q1 2026 at Arvinas, up from -$67.4 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $82.9 million in Q1 2025 to a low of -$154.8 million in Q4 2023.
  • Historically, Consolidated Net Income has averaged -$57.3 million across 5 years, with a median of -$63.3 million in 2022.
  • The sharpest annual moves came in 2025 and 2026: Consolidated Net Income soared 219.45% in 2025, then sank 169.48% in 2026.
  • A 5-year view of Consolidated Net Income shows it stood at -$80.1 million in 2022, then plunged by 93.26% to -$154.8 million in 2023, then jumped by 70.87% to -$45.1 million in 2024, then slumped by 49.45% to -$67.4 million in 2025, then advanced by 14.54% to -$57.6 million in 2026.
  • The last three Consolidated Net Income figures came in at -$57.6 million (Q1 2026), -$67.4 million (Q4 2025), and -$35.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Arvinas 492.16 Mn -122.74 Mn - -57.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -57.60 Mn
Dec 31, 2025 -67.40 Mn
Sep 30, 2025 -35.10 Mn
Jun 30, 2025 -61.20 Mn
Mar 31, 2025 82.90 Mn
Dec 31, 2024 -45.10 Mn
Sep 30, 2024 -49.20 Mn
Jun 30, 2024 -35.20 Mn
Mar 31, 2024 -69.40 Mn
Dec 31, 2023 -154.80 Mn
Sep 30, 2023 -63.90 Mn
Jun 30, 2023 -65.30 Mn
Mar 31, 2023 -80.80 Mn
Dec 31, 2022 -80.10 Mn
Sep 30, 2022 -63.30 Mn
Jun 30, 2022 -67.50 Mn
Mar 31, 2022 -61.10 Mn
Dec 31, 2021 -46.10 Mn
Sep 30, 2021 -46.80 Mn
Jun 30, 2021 -50.30 Mn